Head-to-head · WeighScore
CoreAge Rx vs Zappy Health
The verdict
CoreAge Rx takes it — 91.8/100 to 63.8/100.
CoreAge Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
CoreAge Rx is also our overall #1 pick — it tops the full scorecard at 91.8/100 (A−).
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | CoreAge Rx | Zappy Health |
|---|---|---|
| WeighScore | 91.8/100 | 63.8/100 |
| Grade | A− | C |
| Scorecard rank | #1 | #272 |
| Semaglutide | $99/mo | $159/mo (compounded) |
| Tirzepatide | $149/mo | $299/mo (compounded) |
| Coverage | All 50 states | 42 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Injection only |
Graded #1 · A−
Strengths
- Flat all-in price with no month-two step-up
- Semaglutide and tirzepatide on one account
- All 50 states, LegitScript-verified
Where it loses points
- Not the cheapest sticker price
- Compounded only
- Pharmacy partner not yet publicly named
Graded #272 · C
FDAWarning letter issued to Kare Solutions, LLC dba Zappy in February 2026. See the FDA warning-letter database.
Strengths
- Both compounded GLP-1 and brand-name Wegovy/Zepbound available
- Flat pricing that doesn't increase as your dose goes up
- Cheaper on longer subscriptions — compounded semaglutide from $159/month
- Online visit with a licensed clinician; no insurance required
Where it loses points
- Third-party reports of an order arriving with an unlicensed-pharmacy label
- Not available in 8 states (HI, AL, AR, CA, KS, MI, MN, MS)
- Operating legal entity isn't clearly disclosed on the site
- Lowest prices require a 9-month commitment
- FDA issued Kare Solutions, LLC dba Zappy a warning letter in February 2026; the letter is public in FDA's warning-letter database
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.